These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20832217)

  • 1. False bisalbuminemia and hyperalphafetoproteinemia.
    Boujelbene A; Hellara I; Neffati F; Najjar MF
    Gastroenterol Clin Biol; 2010 Nov; 34(11):636-8. PubMed ID: 20832217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of bisalbuminemia in a patient with digestive adenocarcinoma].
    Hajoui FZ; Biaz A; Zouiten L; Mechtani S; Dami A; Bouhsain S; Ouzzif Z
    Ann Biol Clin (Paris); 2015; 73(2):190-4. PubMed ID: 25847742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A predictive model for pancreatic cancer using serum protein footprint map].
    Long J; Di Y; Jin C; Yu XJ; Liu WW; Chen YM; Fu DL; Ni QX
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1533-6. PubMed ID: 18956633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved resolution of serum bisalbumin on electrophoresis and investigation of bisalbumin in urine.
    Donnelly JL; Higgins TN
    Clin Biochem; 2005 Jul; 38(7):654-8. PubMed ID: 16009143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum].
    Ial'chenko NA; Lagutin VD; Lavik NN; Musin II
    Vopr Onkol; 1991; 37(9-10):921-4. PubMed ID: 1726842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum protein electrophoresis: comparison of capillary zone electrophoresis Capillarys (Sebia) and agarose gel electrophoresis Hydrasys (Sebia)].
    Lissoir B; Wallemacq P; Maisin D
    Ann Biol Clin (Paris); 2003; 61(5):557-62. PubMed ID: 14671753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical applications of serum tumor markers in gastroenterology].
    González Martínez M; Marín López E
    Rev Gastroenterol Mex; 1993; 58(2):103-7. PubMed ID: 7747020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma.
    Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
    Ital J Gastroenterol; 1994 May; 26(4):169-73. PubMed ID: 7949259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying markers for pancreatic cancer by gene expression analysis.
    Zhou W; Sokoll LJ; Bruzek DJ; Zhang L; Velculescu VE; Goldin SB; Hruban RH; Kern SE; Hamilton SR; Chan DW; Vogelstein B; Kinzler KW
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):109-12. PubMed ID: 9488584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum determination of CA 19-9 in diagnosing pancreatic cancer: an obituary.
    Pezzilli R; Casadei R; Calculli L; Santini D; Morselli-Labate AM;
    Dig Liver Dis; 2010 Jan; 42(1):73-4. PubMed ID: 19473891
    [No Abstract]   [Full Text] [Related]  

  • 13. The value of combined use of serum tumour markers and nuclear magnetic spectroscopy of plasma in the detection of pancreatic cancer among patients with jaundice or cholestasis: results from a prospective study.
    Pasanen PA; Kauppinen R; Eskelinen M; Partanen K; Pikkarainen P; Alhava E
    Anticancer Res; 1993; 13(3):763-8. PubMed ID: 8317910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisalbuminemia in chronic kidney disease.
    Ejaz AA; Krishna M; Wasiluk A; Knight JD
    Clin Exp Nephrol; 2004 Sep; 8(3):270-3. PubMed ID: 15480907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of the tumour markers CA 195 and CEA in patients with adenocarcinoma of the pancreas.
    Taylor OM; Cooper EH; Benson EA; McMahon MJ
    Eur J Surg Oncol; 1992 Oct; 18(5):508-13. PubMed ID: 1426303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference Rendering Capillary Electrophoresis of Serum Proteins Uninterpretable.
    Biaz A; Uwingabiye J; Benaissa E; Owusu EM; Idrissi SEM; Dami A; Ouzzif Z; Bouhsain S
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA19-9: the Italian experience.
    Gullo L
    Pancreas; 1994 Nov; 9(6):717-9. PubMed ID: 7846014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEACAM1, a novel serum biomarker for pancreatic cancer.
    Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
    Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisalbuminemia during remission of nephrotic syndrome.
    Akhmouch I; Alayoud A; Bahadi A; Zajjari Y; Montasser D; El Allam M; Oualim Z
    Saudi J Kidney Dis Transpl; 2012 Nov; 23(6):1251-3. PubMed ID: 23168859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisalbuminemia accompanying bisalbuminuria detected in capillary electrophoresis, not in gel electrophoresis.
    Yang HS; Cho SY; Kim YJ; Park TS; Lee HJ
    Clin Chem Lab Med; 2016 Jul; 54(7):e191-3. PubMed ID: 26684351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.